Status:
COMPLETED
Median Effective Dose of Dexmedetomidine in Elective Upper Limb Lidocaine Intravenous Regional Anesthesia
Lead Sponsor:
South Valley University
Collaborating Sponsors:
Tanta University
Conditions:
Intravenous Drug Usage
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
Auxiliary drugs augment the effect of local anesthetic in intravenous regional anesthesia (IVRA). The purpose of our study was to estimate the median effective dose (ED50) of Dexmedetomidine in electi...
Detailed Description
Since its innovation in 1908 by Dr August Bier of Germany, Intravenous regional anesthesia (IVRA) has stood the test of time as simple, safe and effective technique of regional anesthesia. 1 The techn...
Eligibility Criteria
Inclusion
- Aged between 18 and 60 years
- American Society of Anesthesiologists physical status I or II
- Undergoing minor upper limb orthopedic surgical procedures in the hand, wrist and forearms including: metacarpal fracture, tendon injury, and carpal tunnel release.
Exclusion
- Allergy to test drugs.
- vascular disease.
- contraindication to tourniquet applications.
- difficulty to manipulate the surgical limb.
- surgery expected to last more than an hour.
- patient refusal
Key Trial Info
Start Date :
August 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2020
Estimated Enrollment :
81 Patients enrolled
Trial Details
Trial ID
NCT04304157
Start Date
August 1 2019
End Date
March 1 2020
Last Update
March 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
South Valley University
Qina, Egypt